Lung Cancer Survival Rate by Stage and Age | Data & Facts

Few numbers in medicine hit quite like the ones attached to a lung cancer diagnosis. The five-year survival rate — that standard yardstick of how long people live after finding out they have the disease — has long been a sobering figure. Overall, about 28.1% of people in the United States survive five years or more, according to the National Cancer Institute’s SEER program (the US cancer registry authority). But that average hides a wide range of outcomes depending on stage, age, and treatment era.

Overall 5-year relative survival: 28.1% ·
Stage 1 5-year survival: 65% ·
Stage 4 5-year survival: <10% ·
1-year survival (all stages): about 40% ·
10-year survival (all stages): about 10%

Survival rates drop steeply as lung cancer advances. The pattern across four stages, based on the latest registry data from the US and UK, shows a stark gradient.

The implication: catching the disease at stage 1 can mean a 6x higher chance of reaching the five-year mark compared to stage 4. Yet most lung cancers are still diagnosed at later stages — a gap that screening programs aim to close.

Is stage 4 lung cancer curable?

Stage 4 lung cancer — cancer that has spread to the other lung, distant lymph nodes, or other organs — is generally not considered curable. The term “cure” in oncology typically means five years of disease-free survival, and for stage 4 that threshold remains out of reach for the vast majority of patients.

What the numbers show: the CDC reports a 5-year relative survival of 9.4% for distant-stage lung cancer. Cancer Research UK (UK’s leading cancer charity) puts the figure in low single digits for stage 4. However, treatment can extend life and improve quality of life. Palliative care, targeted therapies, and immunotherapy have pushed median survival from months to, in some cases, a few years.

The paradox: stage 4 is not curable, yet it is not a uniform death sentence. Some people live far beyond the average, especially those with certain genetic markers (like EGFR mutations) who respond to oral targeted drugs. But the overall cure rate remains effectively zero.

What is your life expectancy with lung cancer?

Life expectancy with lung cancer depends heavily on the stage at diagnosis and the person’s age. Oncology Nurse Advisor (nursing clinical resource) pegs the overall 5-year relative survival at 26.7% for the 2014–2020 period.

Stage 1 lung cancer survival rate

• 5-year relative survival: 65% according to Roy Castle Lung Cancer Foundation; 60.6% per CDC.
• WebMD (consumer health publisher) reports that stage IA1 (small, early) has a 5-year survival around 90%.
• Surgery offers the best chance of cure at this stage.

Stage 2 lung cancer survival rate

• 5-year survival estimates range from 34.6% (CDC) to 40% (Roy Castle Foundation).
• Surgery combined with chemotherapy is the typical approach; node involvement lowers odds.

Stage 3 lung cancer survival rate

• 5-year survival: 13–36% depending on substage and health. Cancer Therapy Advisor (oncology clinical resource) cites 13–36%.
• Treatment usually combines chemotherapy, radiation, and sometimes immunotherapy.

Stage 4 lung cancer survival rate by age

• 5-year survival is uniformly below 10%, but age matters. Cancer Therapy Advisor reports age-stratified 5-year survival of 42% for ages 20–44, 22% for ages 65–74, and declining further for older groups.
• Patient Power (patient advocacy resource) notes around 35% for people under 45, compared to a 27% average.
• Why younger patients tend to do better: fewer comorbidities, better performance status, and often more aggressive treatment tolerance.

What does end stage lung cancer look like?

End-stage lung cancer refers to stage 4 disease that has become resistant to treatment. The NHS (UK national health service) outlines symptoms: severe shortness of breath, persistent cough (often with blood), intense fatigue, and pain in the chest or bones.

During the final weeks to months, care shifts exclusively to comfort. Hospice services manage pain, breathlessness, and anxiety. Life expectancy at this stage is typically measured in weeks rather than months.

What this means: end-stage lung cancer is not a single moment but a gradual decline. The focus moves from extending life to maximizing quality in the time left.

Is lung cancer 100% curable?

No, lung cancer is not 100% curable overall. The only group with a high probability of cure is stage 1 patients who undergo successful surgery and remain cancer-free for five years. Cancer Research UK states that “cure” is defined as 5-year disease-free survival.

SEER notes that localized (stage 1) lung cancer has about a 60% cure rate. But because most patients are diagnosed at later stages, the overall cure rate for all lung cancers hovers around 20%. Lung cancer remains the leading cause of cancer death in both men and women in the US and UK.

What is the 2 week rule for lung cancer?

The 2-week rule is an NHS (UK national health service) urgent referral pathway. If a patient presents with symptoms suspicious for lung cancer — a cough lasting more than three weeks, coughing up blood, unexplained chest pain, or weight loss — their GP must refer them for a specialist appointment within two weeks.

The aim: catch lung cancer early when survival rates are highest. The NHS reports that more than 4 out of 10 people diagnosed with lung cancer are aged 75 and over, and the disease is rare under 40. The 2-week rule is designed to accelerate diagnosis for those most at risk.

The pattern: the 2-week rule works as a safety net, but awareness remains low. Many people ignore early symptoms or attribute them to smoking or aging.

Here are perspectives from two authoritative sources on what survival looks like.

“Almost 65 out of 100 people with stage 1 lung cancer will survive their cancer for 5 years or more.”

Cancer Research UK (UK cancer research charity)

“About 2 in 5 people with the condition live for at least 1 year after diagnosis.”

NHS (UK national health service)

The consequences: survival statistics are population averages, not individual predictions. But they drive policy — screening, funding, and the urgency of early referral. For a 60-year-old smoker with a persistent cough, the 2-week rule could be the difference between a 65% and a 10% survival chance.

For a more comprehensive breakdown of how these statistics vary, see this detailed lung cancer survival guide by stage and age.

Frequently asked questions